Patents by Inventor Kristian Strømgaard

Kristian Strømgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides
    Patent number: 12240921
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Grant
    Filed: May 10, 2024
    Date of Patent: March 4, 2025
    Assignee: Teitur Trophics ApS
    Inventors: Anders Dalby, Simon Mølgaard Jensen, Mathias Kaas Ollendorff, Kristian Strømgaard, Keld Fosgerau
  • SOLID-PHASE SUPPORTED RADIOLABELING OF PEPTIDES
    Publication number: 20240409578
    Abstract: The invention regards a method for 18F-labeling of a peptide.
    Type: Application
    Filed: January 26, 2022
    Publication date: December 12, 2024
    Inventors: Kristian STRØMGAARD, Matthias Manfred HERTH, Andreas KJÆR, Eduardo Felipe Alves FERNANDES, Line Bruhn Schneider KNUDSEN
  • NOVEL PEPTIDES
    Publication number: 20240301005
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Application
    Filed: May 10, 2024
    Publication date: September 12, 2024
    Inventors: Anders DALBY, Simon Mølgaard JENSEN, Mathias Kaas OLLENDORFF, Kristian STRØMGAARD, Keld FOSGERAU
  • Viral multimeric peptide constructs for targeting PDZ domains
    Publication number: 20230348540
    Abstract: The present invention relates to virally expressed peptides which bind to PDZ domains and thereby block PDZ domain mediated protein-protein interactions and expression vectors encoding these peptides. The virally expressed peptides comprise an oligomerization domain, capable of forming higher order constructs, such as trimers or tetramers, and a peptide ligand capable of binding to a PDZ domain. The invention furthermore relates to therapeutic use of said peptides and expression vectors encoding these peptides.
    Type: Application
    Filed: March 5, 2021
    Publication date: November 2, 2023
    Inventors: Andreas Toft Sørensen, Kenneth Madsen, Nikolaj Christensen, Kristian Strømgaard
  • CYCLIC PEPTIDE INHIBITORS OF PSD-95 AND USES THEREOF
    Publication number: 20230220021
    Abstract: The present invention relates novel cyclic peptides which can act as inhibitors of protein-protein interactions, specifically by inhibiting the PDZ2 domain of PSD-95, as well as their use in treatment of excitotoxic-related diseases and neuropathic pain.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Javier Rodriguez Balboa, Kristian Strømgaard, Søren Østergaard
  • GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES
    Publication number: 20230183335
    Abstract: The present invention relates to a conjugated molecule comprising a peptide displaying at least 0.1% activity of native glucagon-like peptide 1 (GLP-1) at the GLP-1 receptor, and an N-methyl-D-aspartate receptor (NMDAR) antagonist, the peptide being covalently bonded to the NMDAR antagonist either directly or through a chemical linker, the conjugated molecule for use in therapy, pharmaceutical composition comprising the conjugated molecule, a method of reducing body weight of a mammal comprising administering the conjugated molecule to the mammal, and a non-therapeutic method of reducing body weight of a mammal comprising orally administering the conjugated molecule to the mammal.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 15, 2023
    Inventors: Christoffer CLEMMENSEN, Anders Bue KLEIN, Jonas Odgaard PETERSEN, Bente Flensborg FRØLUND, Kristian STRØMGAARD
  • VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF
    Publication number: 20220033450
    Abstract: The present invention relates to virally expressed peptides with high affinity for the PDZ domains, such as the PDZ domain of PICK1. The invention furthermore relates to the therapeutic use of these peptides in prevention and/or treatment of diseases and/or disorders associated with maladaptive plasticity and/or transmission.
    Type: Application
    Filed: October 22, 2019
    Publication date: February 3, 2022
    Applicant: University of Copenhagen
    Inventors: Andreas Toft Sørensen, Kenneth L. Madsen, Nikolaj Riis Christensen, Kristian Strømgaard
  • INHIBITORS OF PICK1 AND USES THEREOF
    Publication number: 20210347821
    Abstract: The present invention relates to peptides and peptide analogues with high affinity for the PDZ domains of PICK1. The peptide or peptide analogue interacts with PICK1, blocking the native protein-protein interactions between PICK1 and its natural ligands. The invention furthermore relates to the therapeutic use of these peptides and peptide analogues in prevention and/or treatment of diseases and disorders associated with maladaptive plasticity, drug addiction and neuropathic pain.
    Type: Application
    Filed: October 22, 2019
    Publication date: November 11, 2021
    Applicant: University of Copenhagen
    Inventors: Kenneth L. Madsen, Kristian Strømgaard, Ulrik Gether, Anders Bach, Nikolaj Riis Christensen
  • FATTY ACID DERIVATIVES OF DIMERIC INHIBITORS OF PSD-95
    Publication number: 20160303245
    Abstract: The present invention provides fatty acid derived compounds capable of binding to the PDZ domains of PSD-95 and their medical use as inhibitors of protein-protein interaction mediated by PSD-95.
    Type: Application
    Filed: November 26, 2014
    Publication date: October 20, 2016
    Inventors: Kristian Strømgaard, Anders Bach, Klaus Bertram Nissen